Medical expulsion therapy for ureteric calculus – possible!
DOI:
https://doi.org/10.18203/2349-2902.isj20160210Keywords:
Adrenergic alpha-antagonists, Tamsulosin, Corticosteroid, Deflazacort, Ureteric calculiAbstract
Background: Objective of the study was to compare the efficacy of combination of Tamsulosin and Deflazacort with that of analgesics alone, in medical expulsive therapy (MET) of solitary ureteric calculus ≤1 cm.
Methods: A prospective randomized study was conducted in 100 patients of Chennai medical college hospital & Research centre from General Surgery and Urology Out-Patient Department (OPD). Patients with symptomatic, solitary ureteric calculus ≤10mm were included. Patients with solitary functioning kidney, history of prior urinary surgery or endoscopic treatment, any associated complication or any contraindications of steroid usage were excluded. Patients were divided into two groups: Group I received Diclofenac 50mg on demand and Group II received Tamsulosin with Deflazacort (0.4mg+30mg respectively) along with analgesic for a maximum of 2weeks.
Results: Calculus expulsion was significantly higher in Group II (84%) compared to that in Group I (60%) (p=0.008). Higher expulsion rate in Group II was primarily seen in the patients with a calculus size of ≥5 mm. There was no difference in stone expulsion rates in patients with stones less than 5mm. 19 patients in group II were free of pain compared to 7 patients in group I (p= 0.006). Group II patients had significant reduction in expulsion time and analgesic requirement.
Conclusions: MET with alpha blocker and steroid combination is effective, safe and economical treatment for symptomatic urolithiasis and scores over treatment with analgesics, alone. This combination can be used as initial therapy for stone expulsion and symptomatic relief, thereby avoiding or delaying surgical intervention in selected patients.
Metrics
References
Ahmed AA, Al Syed AS. Tamsulosin versus alfuzosin in the treatment of patients with distal ureteral stones: prospective, randomized, comparative study. Korean J Urol. 2010;51:193.
Smith RD, Shah M, Patel A. Recent advances in management of ureteral calculi. F1000 Med Reports. 2009;1:53.
Finlayan B, Ackermann D. Overview of surgical management of urolithiasis with special reference to lithotripsy. J Urol. 1989;141:778-9.
Extracorporeal shockwave lithotripsy (ESWL) and endourology; an ideal combination for the treatment of kidney stones. World J Urol. 1985;3:41-7.
Daniels GF Jr, Garnett JE, Carter MF. Ureteroscopic results and complications: experience with 130 cases. J Urol. 1988;139:710-3.
Lotan Y, Gettman MT, Roehrborn CG, Cadeddu JA, Pearle MS. Management of ureteral calculi: a cost comparison and decision making analysis. J Urol. 2002;167:1621-9.
Russell RC, Williams NS, Bulstrode CJ. The kidneys and ureters. Bailey and Love’s Short Practice of Surgery. New York: Edward Arnold; 4th ed. 2004. p. 1321-33.
Marshall LS. Urinary stones diseases. In: Amend WJ Jr, Barbour S, Baskin LS, Berger TG, Bloom AL, Bretan PN Jr. editors. Smith’s Urology.16th Ed. New York: McGraw Hill; 2004. p. 256-90.
Ueno A, Kawamura T, Ogawa A, Takayasu H. Relation of spontaneous passage of ureteral calculi to size. Urology. 1977;10:544.
Miler OF, Kane CJ. Time to stone passage for observed ureteral calculi: A guide for patient education. J Urol. 1999;162:688-91.
Malin JM Jr, Deane RF, Boyarsky S. Characterisation of adrenergic receptors in human ureter. Br J Urol. 1970;42:171-4.
Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K. Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol. 2007;14:749-53.
Weiss RM, Bassett AL, Hoffman BF. Adrenergic innervations of the ureter. Invest Urol. 1978;16:123-7.
Pricop C, Novac C, Negru D, liie C, Pricop A. Can selective alpha blockers help the spontaneous passage of the stones located in the uretero bladder junction. Rev Med Chir Soc Med Nat. 2004;108:128-33.
Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical uretral stones. J Urol. 2003;170:2202-5.
Ukhal M, Malomuzh O, Strashny V. Administration of doxazosine for speedy elimination of stones from lower part of ureter. Eur Urol. 1999;35(Suppl 2):4.
Cervenakov I, Fillo J, Mardiak J, et al. Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker-tamsulosin. Int Urol Nephrol. 2002;34:25-9.
Hollingsworth JM, Rogers MA, Kaufman SR. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet. 2006;368:1171-9.
Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol. 2005;173:2010-12.
Cervenakov l, Fillo J, Mardiak J, Kopecny M, Smirala J, Lepies P. Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1 blockers-tamsulosin. Int J urol Nephrol. 2002;34:25.
Dellabella M, Milanese G, Muzzonigro G. Medical expulsive therapy for distal ureterolithiasis: Randomized prospective study on role of corticosteroids used in combination with tamsulosin – simplified treatment regimen and health related quality of life. Urology. 2005;66:712-5.
Cooper JT, Stack GM, Cooper TP. Intensive medical management of ureteral calculi. Urology. 2000;56:575;
Porpiglia F, Vaccino D, Billia M, Renard J, Cracco C, Ghignone G. Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association? Eur Urol. 2006,50:339- 44.
Bensalah K, Pearle M, Lotan Y. Cost effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones. Eur Urol. 2008,53:411-8.
Downloads
Published
How to Cite
Issue
Section
